1. Home
  2. ATGL vs BCYC Comparison

ATGL vs BCYC Comparison

Compare ATGL & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Technology Group Limited

ATGL

Alpha Technology Group Limited

N/A

Current Price

$20.15

Market Cap

503.9M

Sector

N/A

ML Signal

N/A

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$7.02

Market Cap

476.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATGL
BCYC
Founded
2017
2009
Country
Hong Kong
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
503.9M
476.6M
IPO Year
2023
2019

Fundamental Metrics

Financial Performance
Metric
ATGL
BCYC
Price
$20.15
$7.02
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$18.73
AVG Volume (30 Days)
39.2K
237.4K
Earning Date
01-27-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,206,460.00
$28,339,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.36
N/A
52 Week Low
$9.01
$6.03
52 Week High
$57.32
$13.66

Technical Indicators

Market Signals
Indicator
ATGL
BCYC
Relative Strength Index (RSI) 41.53 53.61
Support Level $18.30 $6.37
Resistance Level $22.10 $7.34
Average True Range (ATR) 4.30 0.33
MACD -0.56 0.06
Stochastic Oscillator 2.21 67.31

Price Performance

Historical Comparison
ATGL
BCYC

About ATGL Alpha Technology Group Limited

Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: